Novotech

Novotech Novotech is a multi-award winning contract research organization (CRO).

Founded in 1997, Novotech is a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase. Founded in 1996, we’re headquartered in Australia, and have offices in Sydney, Brisbane and Melbourne, and across the Asia-Pacific region, including China, Hong Kong, India, Mal

aysia, New Zealand, Philippines, Singapore, South Korea, Taiwan and Thailand. We’re internationally recognized in the industry as a leading regional full-service CRO, with services including clinical trials, biostatistics, data management, regulatory affairs, audits and medical writing.

Today is International Clinical Trials Day.It’s a moment to recognize the people behind every clinical trial, working ac...
20/05/2026

Today is International Clinical Trials Day.

It’s a moment to recognize the people behind every clinical trial, working across teams and regions to keep progress moving forward.

Clinical trials are complex, but they succeed because of the people involved at every step.

At Novotech, we are proud to partner with teams around the world who are helping shape the future of healthcare through clinical research.

11/05/2026

We’re pleased to welcome Elaina N. Haeuber, MS as Senior Vice President, Global Project Management at Novotech.

With more than 20 years of global experience in clinical development and operations, Elaina has led complex, multinational programs and built high-performing teams.

Her appointment strengthens our global project management capability as we continue to support increasingly complex development programs.

Join us in welcoming Elaina to the Novotech team.

07/05/2026

We’re excited to welcome Susan Johnson as Managing Director, North America at Novotech.

Susan brings 20+ years of experience in clinical operations across biotech, pharma, and CROs, with a strong track record leading complex programs and partnering closely with sponsors.

Her appointment further strengthens our North America leadership as we continue to support increasingly complex development programs.

Please join us in welcoming Susan to the team.

Strong clinical programs start with the right foundations: access to the right sites and realistic feasibility from day ...
06/05/2026

Strong clinical programs start with the right foundations: access to the right sites and realistic feasibility from day one.

At Novotech, we’re taking a more integrated approach—bringing site engagement, partnerships, and feasibility together to drive better outcomes for both delivery and growth.

We’re currently looking for a Senior Director, Site Engagement & Feasibility to lead this effort within our Clinical Operations team.

This is a global role, working across Clinical, Therapeutic Strategy, Commercial, and Executive Leadership—connecting site strategy with study planning and ex*****on.

If you’ve worked in this space, you know how impactful this can be.

Apply Now: https://fa-euzi-saasfaprod1.fa.ocs.oraclecloud.com/hcmUI/CandidateExperience/en/sites/CX_1/job/3871

01/05/2026

We’re pleased to welcome Kristin Brown as our new Chief Legal Officer.

Kristin brings over 20 years of global leadership experience, having led Legal, Risk, Internal Audit and ESG functions, driven major transformation initiatives, strengthened governance frameworks, and enhanced operational efficiency through technology.

She has extensive experience advising executive teams on legal, regulatory and risk strategy across APAC, EMEA, the Middle East and the US.

In her new role, Kristin will partner with our executive team to strengthen capabilities and support our continued global growth.

Welcome, Kristin.

Rare diseases may be uncommon individually, but they affect millions of people worldwide.Behind every diagnosis is a per...
28/02/2026

Rare diseases may be uncommon individually, but they affect millions of people worldwide.

Behind every diagnosis is a person and a family navigating complex care needs and uncertainty. Advances in science are creating new hope, but continued collaboration and research remain critical.

On Rare Disease Day, we recognize the resilience of the rare disease community and the importance of patient-focused progress.

04/02/2026

Today on World Cancer Day 2026, we stand with patients, caregivers, clinicians, and researchers, recognizing that every cancer journey is unique. Oncology has evolved dramatically from limited treatment options to precision medicine and immuno-oncology approaches that are improving outcomes and personalizing care.

We are proud to partner with sponsors to support the development of new cancer therapies and help bring meaningful treatment options to patients worldwide.

08/01/2026

Novotech has appointed Dr. Anand Tharmaratnam as its new Chief Executive Officer. Dr. Tharmaratnam brings nearly 30 years of experience in the global CRO industry and commenced as Chairman and CEO on 1 January 2026. He will be based at the company’s new global headquarters in Singapore. Full announcement: https://ow.ly/HW4m50XTf3T

As the year draws to a close, we want to say thank you to our employees around the world, and to our clients and partner...
29/12/2025

As the year draws to a close, we want to say thank you to our employees around the world, and to our clients and partners. Your hard work, trust, and collaboration are at the heart of everything we do, fundamental to our shared purpose of advancing clinical research for patients and communities worldwide. We are proud of what we have achieved together this year and deeply grateful for the relationships that make it possible.

From all of us at Novotech, we extend our best wishes for a safe and restful holiday season and continued success in the year ahead.

02/12/2025

On World AIDS Day, we recognize the researchers, clinicians, trial teams, and community partners whose work has moved HIV from crisis to chronic care and opened a clearer path toward durable remission and, one day, a cure. Modern antiretroviral therapy (ART) enables long, healthy lives and U=U (Undetectable = Untransmittable). Long-acting options are expanding choice, and cure research is advancing across antibodies, latency strategies, and gene-based approaches. Today, an estimated 40.8 million people live with HIV, and each breakthrough improves outcomes for millions.

Novotech is proud to support this progress through HIV studies across North America, Europe, and APAC, with 20 trials to date focused on inclusive design, reliable operations, and data that accelerates access.

Talk to an expert: https://ow.ly/lIy450XAs3W

Address

Level 52, 9 Raffles Place, Republic Plaza
Central Region
048619

Alerts

Be the first to know and let us send you an email when Novotech posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Novotech:

Share